ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0889

Association of Subjective Cognitive Report Using PDQ-20 to a Neuropsychological Battery in a Cohort of SLE Patients

Ambika Gupta1, Sindhu Johnson2, Jiandong Su3, Andrea Knight4, Juan Diaz-Martinez5, Kathleen Bingham6, Mahta Kakvan3, Maria Tartaglia3, Lesley Ruttan6, Joan Wither3, May Choi7, Marvin Fritzler8, Dennisse Bonilla3, Dorcas Beaton9, Patricia Katz10, Robin Green3 and Zahi Touma1, 1University of Toronto, Mississauga, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3University Health Network, Toronto, ON, Canada, 4Hospital for Sick Children, Toronto, ON, Canada, 5UHN, Toronto, ON, Canada, 6University of Toronto, University Health Network, Toronto, ON, Canada, 7Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada, 8University of Calgary, Calgary, AB, Canada, 9Institute for Work & Health, Toronto, ON, Canada, 10University of California San Francisco, San Francisco, CA

Meeting: ACR Convergence 2021

Keywords: Cognitive dysfunction, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 7, 2021

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II: Manifestations (0855–0896)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Systemic Lupus Erythematosus (SLE) can lead to a number of neuropsychiatric manifestations including cognitive impairment (CI). Previous meta-analyses have reported the prevalence of CI at 38% (95% confidence interval: 33-43%), with a range of 15-79%. Comprehensive neuropsychological battery (NB) of tests is considered the gold standard when diagnosing CI. We aim to compare a subjective questionnaire, the perceived deficits questionnaire (PDQ-20) to the NB and also to other patient reported outcomes, in an SLE cohort.

Methods: This is a cross-sectional study of consecutive consenting patients, aged 18-65 years, who attended a single center (Jul 2016 – Mar 2019). Each patient completed a comprehensive NB evaluating six cognitive domains including: manual motor speed and dexterity, simple attention and processing, visual spatial construction, verbal fluency, learning and memory (verbal and visuospatial) and executive function. They also completed the 20 item PDQ-20 questionnaire (subjective cognitive function) along with other patient reported outcome questionnaires such as the Beck anxiety score, Beck depression score, fatigue severity score (FSS), Short Form Health Survey (SF-36) domains [Role Physical, Mental Health, Bodily Pain, General Health, Physical Functioning, Emotional, Social Functioning, and Vitality domains].

The variable of main interest was the total score of 19 tests in NB, along with patients’ demographics, lupus disease activity, organ damage, treatment and other PROs. Mean ± std., median (interquartile range) and count (%) were calculated for these variables. Univariate and multivariable linear regressions were performed to evaluate the associated factors with total PDQ-20 scores. Least Absolute Shrinkage and Selection Operator (LASSO) method was used in the variable selection in multivariable model building process. Linear model assumptions were tested by residual density plots and quantile-quantile plots.

Results: Data on 238 patients was analysed; 89.9% were females with an average age and SLE duration at baseline visit of 41.1 ± 12.1 and 14.3 ± 10.0 years, respectively. In the univariate analysis, PDQ-20 was associated with the NB, SDI, fatigue severity score (FSS), BECK anxiety and depression score and all SF-36 domains (Table 1). In the multivariate analysis, PDQ-20 was significantly associated with female gender, SDI, fatigue, BECK depression and anxiety scores, SF-36 Role Emotional domain and glucocorticoid dosage. PDQ-20 was not associated with the NB. There was also no association with age at first visit, SLE disease duration, ethnicity, education level, SLEDAI score, anti-malarial or immunosuppressive treatment with the PDQ-20 score.

Conclusion: Subjective cognitive report by PDQ-20 was associated with the NB in univariate analysis but not multivariate analysis. While PDQ-20 was associated with all SF-36 domains in the univariate analysis, this association was significant only with Role Emotional in the multivariate analysis. There was a clear association of PDQ-20 with other subjective patient reported outcomes (such as fatigue, anxiety and depression, and SF-36 Role Emotional domain).


Disclosures: A. Gupta, None; S. Johnson, None; J. Su, None; A. Knight, None; J. Diaz-Martinez, None; K. Bingham, None; M. Kakvan, None; M. Tartaglia, None; L. Ruttan, None; J. Wither, None; M. Choi, MitogenDx, 1, 2; M. Fritzler, Inova Diagnostics Inc., 2, 6, Werfen International, 2, Alexion Canada, 6, Mitogen Diagnostics Corp., 3, 8, 9, 10; D. Bonilla, None; D. Beaton, None; P. Katz, None; R. Green, None; Z. Touma, AbbVie Inc, 2, UCB Biopharma SRL, 2, Sarkana Pharma Inc., 1, 4, Janssen Inc., 2, GlaxoSmithKline Inc., 6.

To cite this abstract in AMA style:

Gupta A, Johnson S, Su J, Knight A, Diaz-Martinez J, Bingham K, Kakvan M, Tartaglia M, Ruttan L, Wither J, Choi M, Fritzler M, Bonilla D, Beaton D, Katz P, Green R, Touma Z. Association of Subjective Cognitive Report Using PDQ-20 to a Neuropsychological Battery in a Cohort of SLE Patients [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/association-of-subjective-cognitive-report-using-pdq-20-to-a-neuropsychological-battery-in-a-cohort-of-sle-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-subjective-cognitive-report-using-pdq-20-to-a-neuropsychological-battery-in-a-cohort-of-sle-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology